Health Care Policy

Use of cannabis for medicinal purposes has generated a lot of attention at the national and international level. There are a lot of controversies revolving around ethical, legal and other implications of use of marijuana. Adverse health effects as well as deaths related to cannabis are some of complex issues related to cannabis. Cannabis is currently recognized as schedule I controlled drugs. It has a high potential of abuse, not accepted for medicinal treatment in the U.S and does not have accepted safety data for it use in treatment under medical supervision (Bridgeman & Abazia, 2017).

One of the stakeholders opposing cannabis use is the law enforcement agencies. In some states, it has become legal to use cannabis, but the police officer’s attitude has not changed regarding the use of cannabis. Another stakeholder opposing cannabis is the big pharmaceutical companies. Such companies are known to run huge operations of conventional medications and as such are in the forefront of opposing the therapeutic benefits of cannabis (Alice, 2018). Lastly is private prisons which feel that legalization of marijuana will lead to less convicts and as such this will reduce their business (Alice, 2018). Stakeholders who are in support of cannabis use for medicinal purposes include citizens and patients. Legalization for medicinal use commonly affects the citizens. There are a variety of applications that cannabis has been said to have for a variety of diseases. Instead of using prescriptions that can have side effects, patients and citizens can use cannabis. Others in support include medical and pharmaceutical communities. These are likely to benefit in handling the ever growing medical needs and offering more options to the patients.

Don't use plagiarized sources. Get Your Custom Essay on
Health Care Policy
Just from $13/Page
Order Essay

There has been an increase in the public debate and research over the pharmacological qualities and effects of marijuana. Most of the research on the use of cannabis for medicinal purposes conclude with a call for further clinical trials (De Vries & Green, 2017). Use of cannabis in oncology is mainly focused on symptoms management such as vomiting and nausea which is associated with chemotherapy (De Vries & Green, 2017). Given this and the fact that there is growing evidence of cannabis potential benefit of slowing neurodegenerative disorders, cannabis use has significantly grown.

Reports shows that there is increased use of cannabinoids in treatment of neurodegenerative diseases and other life-limiting conditions. There is also increased use of cannabis use for therapeutic benefits from illegal consumptions (De Vries & Green, 2017). With increased legalization and approval for medicinal use, there will be widespread use of marijuana for medicinal purposes. In future, more policies will be created to regulate cannabis medical use as well as more states will legalize the use of cannabis. Nurses at some points will be advocating for use of cannabis in patients.

References

 

Alice. (2018, July 6). Stakeholders that oppose cannabis legalization – I love growing marijuana. Retrieved from http://www.ilovegrowingmarijuana.com/stakeholders-oppose-cannabis-legalization/

 

Bridgeman, M. B., & Abazia, D. T. (2017). Medicinal cannabis: History, pharmacology, and implications for the acute care setting. Pharmacy and Therapeutics, 42(3), 180.

 

De Vries, K., & Green, A. J. (2017, February 24). Therapeutic use of cannabis. Retrieved from https://www.nursingtimes.net/clinical-archive/end-of-life-and-palliative-care/therapeutic-use-of-cannabis/5041821.article

ORDER NOW »»

and taste our undisputed quality.